OB-GYNs dispute safety of abortion pill amid court battle

Published




Obstetrician-gynecologists are disputing the safety of the abortion pill mifepristone as litigation on Food and Drug Administration approval makes its way through the courts.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.